healthcare stocks Archives

Illustration of a bullish investment landscape showing AI-powered ecommerce, healthcare innovation, cybersecurity and market growth. Robots manage online-shopping fulfillment around an ecommerce screen, clinicians and researchers work in a modern medical setting, and professionals point toward rising stock charts and upward arrows, with the phrases “AI Commerce,” “Healthcare” and “Stay Engaged.”

A Resilient Economy, AI Commerce & Healthcare Catalysts Give Many More Than One Reason to Stay Engaged -( $AMWL $AMZN $APPL $CRWD $GOOG $OKTA $PANW $PYPL $SER $SHOP $SMWB $XYZ $ZS )

by John F. Heerdink, Jr. 3 hours ago 120Views 0Likes

Many entered the week bracing for a Federal Reserve rate hike, yet the more constructive takeaway may be that policy makers still have room to choose patience. That possibility, alongside fresh evidence of AI-led ecommerce change, government-scale digital-health demand and advancing biotech milestones,…

Illustrated weekly market summary graphic for September 11 showing rising stock-market charts and green bar graphs alongside an inflation gauge, oil pumpjack, Federal Reserve building, rate-hike headlines, supply-chain pressure reports and global economic uncertainty imagery.

Weekly Market Summary – Sept. 11: Stocks Rebound as Inflation, Oil and Fed Risks Take Center Stage -( $AMWL $DELL $DOCS $EPRX $EXOD $HPP $LPL $SOC $T $TE $TMUS $YSG Rise! )

by John F. Heerdink, Jr. 3 days ago 9696Views 0Likes

NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.

Business presenters at an investor conference stand beside a screen reading “Apple and Amwell Signal a New Premium Cycle for Tech and Digital Health,” highlighting integrated wearables, virtual-care expansion and data-driven insights.

Apple and Amwell Signal a New Premium Cycle for Tech and Digital Health -( $AAPL $AMWL $DELL $HPE $MSFT $TSLA )

by John F. Heerdink, Jr. 5 days ago 284Views 0Likes

Apple Inc. (NASDAQ: AAPL) is betting that the next smartphone upgrade cycle will fold neatly into consumers’ pockets, while Amwell (NYSE: AMWL) is positioning its virtual-care platform for a potentially consequential role inside the U.S. Department of Veterans Affairs. Together, the developments…

Serina Therapeutics Clears a Key Parkinson’s Hurdle -( $PFE $SER $XBI )

by John F. Heerdink, Jr. September 9, 2026 189Views 0Likes

Serina Therapeutics, Inc. (NYSE American: SER) has moved its lead Parkinson’s disease program from promise on paper to progress in patients. After an independent safety committee completed its blinded review of the first cohort in the Company’s Phase 1b registrational study, Serina received…

Surreal financial illustration depicting Amwell’s potential U.S. Department of Veterans Affairs digital-health opportunity: a luminous “Letter of Intent” scroll marked “Amwell–VA Partnership,” a rising green arrow shaped like a fountain pen, “VA $AMWL” lettering, healthcare symbols, documents, and a winding road toward a futuristic city beneath a star-filled sky.

Amwell’s VA Letter of Intent Could Mark a Defining Turn for $AMWL

by John F. Heerdink, Jr. September 8, 2026 221Views 0Likes

Amwell (NYSE: AMWL) has received a Letter of Intent from the U.S. Department of Veterans Affairs to deploy its virtual health platform across the VA enterprise, positioning the digital-care company at the center of a potentially consequential modernization effort serving more than 9…

Digital Nasdaq billboard in Times Square highlighting Eupraxia Pharmaceuticals (NASDAQ: EPRX), its Nasdaq Global Select Market upgrade, and the upcoming eosinophilic esophagitis clinical-data catalyst.

Eupraxia Pharmaceuticals’ Nasdaq Upgrade Sets the Table for a High-Stakes EoE Catalyst -( $EPRX $SNY $XBI )

by John F. Heerdink, Jr. September 8, 2026 189Views 0Likes

Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX) has moved up to the Nasdaq Global Select Market just as its lead clinical program approaches a pivotal Phase 2b interim data event. For many, the timing is rather tidy: the company is pairing greater market…

Illustration of an older man with Parkinson’s symptoms beside a laboratory researcher holding a syringe, with a large brain diagram showing dopamine pathways, sustained drug release, motor control, and Serina Therapeutics’ Parkinson’s disease drug-delivery innovation.

Serina Therapeutics: A Parkinson’s Story Where Better Drug Delivery Could Become the Main Event -( $PFE $SER $XBI )

by John F. Heerdink, Jr. September 8, 2026 220Views 0Likes

Serina Therapeutics, Inc. (NYSE American: SER) is building a potentially compelling clinical and platform-driven story around a familiar biotech proposition: take a medicine with demonstrated utility, improve the way it behaves in the body, and create a product patients may find meaningfully…

Investor-themed graphic showing Tribe Public and ACOG logos above a rising green-and-gold stock chart, dollar signs, and the Zunveyl (benzgalantamine) 5 mg, 10 mg, and 15 mg branding against a modern city backdrop.

Alpha Cognition’s Commercial Alzheimer’s Story Is Getting Harder to Ignore -( $ACOG )

by John F. Heerdink, Jr. September 6, 2026 166Views 0Likes

Alpha Cognition Inc. (NASDAQ: ACOG) has moved meaningfully beyond the familiar small-cap biotech ritual of promising future potential. Since CEO Michael McFadden’s January 15, 2026 Tribe Public luncheon presentation during the J.P. Morgan Healthcare Conference week in San Francisco, the company has paired…

Investor infographic illustrating Eli Lilly and Company (NYSE: LLY) investing up to $2.875 billion to acquire Merida Biosciences, linking Lilly’s headquarters and cash investment to Merida’s antibody-engineering candidates, precision immunology research, and projected future revenue growth.

Eli Lilly’s $2.875 Billion Immunology Bet: Why Merida Could Be More Than a Pipeline Add-On -( $IBB $LLY $XBI )

by John F. Heerdink, Jr. September 1, 2026 205Views 0Likes

Eli Lilly and Company (NYSE: LLY) is making a confident and distinctly forward-looking move beyond its blockbuster obesity and diabetes franchises. Its agreement to acquire privately held Merida Biosciences for up to $2.875 billion in cash is a bullish vote for precision immunology:…

Alt text: Illustration of OpenAI’s $1 billion AI monetization opportunity, featuring AI-powered advertising dashboards, robots, digital healthcare consultations, data centers, drones, financial charts and connected technology infrastructure representing growth in artificial intelligence, telehealth and the broader market economy.

AI Monetization, Digital Care, and a Macro Backdrop Built for Builders? -( $AMWL $AMZN $GOOGL $META $MSFT $NVDA $OPAI.PVT $TTD )

by John F. Heerdink, Jr. August 31, 2026 188Views 0Likes

The market’s most investable theme today is not simply artificial intelligence, healthcare or macroeconomics in isolation. It is possibly the increasingly visible convergence of all three: businesses finding ways to monetize AI, healthcare platforms turning operational discipline into financial leverage, and policymakers…

Tag: healthcare stocks

A Resilient Economy, AI Commerce & Healthcare Catalysts Give Many More Than One Reason to Stay Engaged -( $AMWL $AMZN $APPL $CRWD $GOOG $OKTA $PANW $PYPL $SER $SHOP $SMWB $XYZ $ZS )

Weekly Market Summary – Sept. 11: Stocks Rebound as Inflation, Oil and Fed Risks Take Center Stage -( $AMWL $DELL $DOCS $EPRX $EXOD $HPP $LPL $SOC $T $TE $TMUS $YSG Rise! )

Apple and Amwell Signal a New Premium Cycle for Tech and Digital Health -( $AAPL $AMWL $DELL $HPE $MSFT $TSLA )

Serina Therapeutics Clears a Key Parkinson’s Hurdle -( $PFE $SER $XBI )

Amwell’s VA Letter of Intent Could Mark a Defining Turn for $AMWL

Eupraxia Pharmaceuticals’ Nasdaq Upgrade Sets the Table for a High-Stakes EoE Catalyst -( $EPRX $SNY $XBI )

Serina Therapeutics: A Parkinson’s Story Where Better Drug Delivery Could Become the Main Event -( $PFE $SER $XBI )

Alpha Cognition’s Commercial Alzheimer’s Story Is Getting Harder to Ignore -( $ACOG )

Eli Lilly’s $2.875 Billion Immunology Bet: Why Merida Could Be More Than a Pipeline Add-On -( $IBB $LLY $XBI )

AI Monetization, Digital Care, and a Macro Backdrop Built for Builders? -( $AMWL $AMZN $GOOGL $META $MSFT $NVDA $OPAI.PVT $TTD )

Your Guide To Staying Informed In The Markets